Gen-Karpaz

Gen-Karpaz: anticonvulsant from Canada

Gene-Carpase, also known as carbamazepine, is an anticonvulsant and is used to treat various diseases such as epilepsy, trigeminal and glossopharyngeal neuralgia, alcohol withdrawal and diabetic neuropathy. This medicine is manufactured by Genpharm Inc. in Canada and belongs to the group of iminostilbenes.

Gene-Karpaz is presented in the form of 200 mg tablets containing the active substance carbamazepine. It may cause side effects such as dizziness, headache, hallucinations, agitation, depression, aggressive behavior, changes in taste and speech disturbances, as well as more serious side effects such as atrioventricular block, hepatitis, renal dysfunction and multiorgan delayed hypersensitivity reactions. type.

Gene-Karpaz has a number of contraindications, including hypersensitivity, atrioventricular block, a history of myelosuppression or acute porphyria, and pregnancy in the first trimester. Its use in combination with MAO inhibitors should also be avoided, and possible interactions with other anticonvulsants and other medications should be taken into account.

Before starting and during therapy, regular monitoring of blood and urine parameters is recommended. An overdose of Gen-Karpaz may cause serious symptoms such as confusion, hallucinations and coma, seizures, myoclonus and respiratory depression.

In general, Gen-Karpaz is an effective anticonvulsant, but its use must be carefully controlled and under medical supervision. If you have any questions or concerns about using Gen-Karpaz, please contact your healthcare professional.